# X thread draft — Rate-Distortion Immunology

**1/12** Immune aging is not simply “less diversity.” A large T-cell clone can be protective; a repertoire with many unique TCRs can still miss a new pathogen. What matters is coverage of a defined target distribution, not entropy alone.

**2/12** We propose a rate-distortion view: define pathogen peptide–HLA targets, a prior over them, and a distortion equal to the modeled probability that all selected receptors miss a target. The prior is an assumption, not a law of nature.

**3/12** For receptor set S, target e, and calibrated response probability rᵢₑ, an initial approximation is qₑ(S)=∏ᵢ∈S(1−rᵢₑ). It assumes conditional independence; correlated TCR recognition needs joint estimates.

**4/12** Weighting target misses gives Dπ(S)=Σₑ πₑℓₑqₑ(S). ℓ=1 gives a modeled miss probability; severity weighting gives expected loss. These are different estimands and must not be mixed.

**5/12** Define a candidate-space coverage gap: observed distortion minus the best distortion among candidates of the same declared codebook budget. The number depends on the prior, HLA, candidate pool, assay and recognition model—not just biological age.

**6/12** Under the independent-miss model, expected coverage is monotone submodular. Adding a receptor has diminishing marginal value. Greedy selection earns a 1−1/e guarantee for the simple fixed-cardinality objective—not automatically for robust or safety-constrained variants.

**7/12** Recent work reports repertoire size and highly expanded-clone abundance explain much of TCRβ diversity in a 30k-person cohort. Other work finds CMV expansion can coexist with preserved diversity. So a big clone ≠ “waste.”

**8/12** AI’s role: estimate receptor–epitope response probabilities, quantify uncertainty, and calibrate on held-out studies. Split by donor AND epitope. Random sequence splits can leak public clonotypes and overstate performance.

**9/12** The prior is the weak point. We propose prior families and stress tests, plus a hard stop when scores are unstable or poorly calibrated. One headline “immune compression score” without sensitivity analysis would be misleading.

**10/12** First empirical test: public AIRR repertoires + experimentally mapped receptor–epitope data, then compare held-out vaccine or infection outcomes against age, sex, CMV, HLA, repertoire size, Hill diversity and top-clone mass. No human dataset was analyzed in this release.

**11/12** Falsification is explicit: if the metric doesn’t add out-of-cohort prediction beyond ordinary diversity/clonality—or collapses under plausible priors—the rate-distortion framing fails as a useful biomarker. Synthetic checks are not biological validation.

**12/12** No human clone-depletion protocol is proposed. The immediate goal is a falsifiable computation, not deleting memory cells. Preprint, source, verifier and data-limitations note: https://github.com/Devanik21/The-Invention-Archive/tree/main/Theoretical%20Research/Rate_Distortion_Immunology_Defragmenting_the_Aging_Immune_Repertoire
